These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 21219422)

  • 1. Proinsulin/C-peptide ratio, glucagon and remission in new-onset Type 1 diabetes mellitus in young adults.
    Schölin A; Nyström L; Arnqvist H; Bolinder J; Björk E; Berne C; Karlsson FA;
    Diabet Med; 2011 Feb; 28(2):156-61. PubMed ID: 21219422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proinsulin, GLP-1, and glucagon are associated with partial remission in children and adolescents with newly diagnosed type 1 diabetes.
    Kaas A; Andersen ML; Fredheim S; Hougaard P; Buschard K; Petersen JS; de Beaufort C; Robertson KJ; Hansen L; Mortensen HB; Nielsen LB;
    Pediatr Diabetes; 2012 Feb; 13(1):51-8. PubMed ID: 22118630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Golimumab and Beta-Cell Function in Youth with New-Onset Type 1 Diabetes.
    Quattrin T; Haller MJ; Steck AK; Felner EI; Li Y; Xia Y; Leu JH; Zoka R; Hedrick JA; Rigby MR; Vercruysse F;
    N Engl J Med; 2020 Nov; 383(21):2007-2017. PubMed ID: 33207093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proinsulin and C-peptide at onset and during 12 months cyclosporin treatment of type 1 (insulin-dependent) diabetes mellitus.
    Snorgaard O; Hartling SG; Binder C
    Diabetologia; 1990 Jan; 33(1):36-42. PubMed ID: 2303172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meal-stimulated glucagon release is associated with postprandial blood glucose level and does not interfere with glycemic control in children and adolescents with new-onset type 1 diabetes.
    Pörksen S; Nielsen LB; Kaas A; Kocova M; Chiarelli F; Orskov C; Holst JJ; Ploug KB; Hougaard P; Hansen L; Mortensen HB;
    J Clin Endocrinol Metab; 2007 Aug; 92(8):2910-6. PubMed ID: 17519307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term metabolic and hormonal effects of exenatide on islet transplant recipients with allograft dysfunction.
    Faradji RN; Froud T; Messinger S; Monroy K; Pileggi A; Mineo D; Tharavanij T; Mendez AJ; Ricordi C; Alejandro R
    Cell Transplant; 2009; 18(10):1247-59. PubMed ID: 20003758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of insulin resistance on proinsulin secretion in pregnancy: hyperproinsulinemia is not a feature of gestational diabetes.
    Retnakaran R; Hanley AJ; Sermer M; Zinman B
    Diabetes Care; 2005 Nov; 28(11):2710-5. PubMed ID: 16249544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of Impending Type 1 Diabetes through Automated Dual-Label Measurement of Proinsulin:C-Peptide Ratio.
    Van Dalem A; Demeester S; Balti EV; Keymeulen B; Gillard P; Lapauw B; De Block C; Abrams P; Weber E; Vermeulen I; De Pauw P; Pipeleers D; Weets I; Gorus FK;
    PLoS One; 2016; 11(12):e0166702. PubMed ID: 27907006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proinsulin to C-Peptide Ratio in the First Year After Diagnosis of Type 1 Diabetes.
    Freese J; Al-Rawi R; Choat H; Martin A; Lunsford A; Tse H; Mick G; McCormick K
    J Clin Endocrinol Metab; 2021 Oct; 106(11):e4318-e4326. PubMed ID: 34228132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin resistance in HIV protease inhibitor-associated diabetes.
    Yarasheski KE; Tebas P; Sigmund C; Dagogo-Jack S; Bohrer A; Turk J; Halban PA; Cryer PE; Powderly WG
    J Acquir Immune Defic Syndr; 1999 Jul; 21(3):209-16. PubMed ID: 10421244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proinsulin immunoreactivity in recent-onset IDDM: the significance of insulin antibodies and insulin autoantibodies.
    Snorgaard O; Kjems LL; Røder ME; Hartling SG; Dinesen B; Binder C
    Diabetes Care; 1996 Feb; 19(2):146-50. PubMed ID: 8718435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced β-Cell Secretory Capacity in Pancreatic-Insufficient, but Not Pancreatic-Sufficient, Cystic Fibrosis Despite Normal Glucose Tolerance.
    Sheikh S; Gudipaty L; De Leon DD; Hadjiliadis D; Kubrak C; Rosenfeld NK; Nyirjesy SC; Peleckis AJ; Malik S; Stefanovski D; Cuchel M; Rubenstein RC; Kelly A; Rickels MR
    Diabetes; 2017 Jan; 66(1):134-144. PubMed ID: 27495225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Earlier triple therapy with pioglitazone in patients with type 2 diabetes.
    Charpentier G; Halimi S;
    Diabetes Obes Metab; 2009 Sep; 11(9):844-54. PubMed ID: 19614944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parallel changes of proinsulin and islet amyloid polypeptide in glucose intolerance.
    MacNamara CM; Barrow BA; Manley SE; Levy JC; Clark A; Turner RC
    Diabetes Res Clin Pract; 2000 Oct; 50(2):117-26. PubMed ID: 10960722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies of insulin and proinsulin in pancreas and serum support the existence of aetiopathological endotypes of type 1 diabetes associated with age at diagnosis.
    Leete P; Oram RA; McDonald TJ; Shields BM; Ziller C; ; Hattersley AT; Richardson SJ; Morgan NG
    Diabetologia; 2020 Jun; 63(6):1258-1267. PubMed ID: 32172310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Normal weight promotes remission and low number of islet antibodies prolong the duration of remission in Type 1 diabetes.
    Schölin A; Törn C; Nyström L; Berne C; Arnqvist H; Blohmé G; Bolinder J; Eriksson JW; Kockum I; Landin-Olsson M; Ostman J; Karlsson FA; Sundkvist G; Björk E
    Diabet Med; 2004 May; 21(5):447-55. PubMed ID: 15089789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural course of remission in IDDM during 1st yr after diagnosis.
    Martin S; Pawlowski B; Greulich B; Ziegler AG; Mandrup-Poulsen T; Mahon J
    Diabetes Care; 1992 Jan; 15(1):66-74. PubMed ID: 1737543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta-cell response to intravenous glucagon in African-American and Hispanic children with type 2 diabetes mellitus.
    Taha DR; Castells S; Umpaichitra V; Bastian W; Banerji MA
    J Pediatr Endocrinol Metab; 2002 Jan; 15(1):59-67. PubMed ID: 11822582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic factors affecting residual beta cell function assessed by C-peptide secretion in patients with newly diagnosed type 1 diabetes.
    Picardi A; Visalli N; Lauria A; Suraci C; Buzzetti R; Merola MK; Manfrini S; Guglielmi C; Gentilucci UV; Pitocco D; Crinò A; Bizzarri C; Cappa M; Pozzilli P
    Horm Metab Res; 2006 Oct; 38(10):668-72. PubMed ID: 17075776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-localisation of the Kir6.2/SUR1 channel complex with glucagon-like peptide-1 and glucose-dependent insulinotrophic polypeptide expression in human ileal cells and implications for glycaemic control in new onset type 1 diabetes.
    Nielsen LB; Ploug KB; Swift P; Ørskov C; Jansen-Olesen I; Chiarelli F; Holst JJ; Hougaard P; Pörksen S; Holl R; de Beaufort C; Gammeltoft S; Rorsman P; Mortensen HB; Hansen L;
    Eur J Endocrinol; 2007 Jun; 156(6):663-71. PubMed ID: 17535866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.